Indeed, in the GEO datasets presented here (GSE6919 and GDS1439), WNT7B, WNT9A and WNT10B were all increased in metastatic prostate cancer, where PHB levels were reduced. Here, PHB1 is linked to metastatic prostate carcinoma.